Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
International Cancer Conference Journal|June 1, 2019
Serous adenocarcinoma of retroperitoneum: a case reportYuki Kohada, Jun Teishima, Yui Hattori, et al.
Oncology|February 15, 2021
BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell CarcinomaYohei Sekino, Xiangrui Han, Go Kobayashi, et al.
The Prostate|July 2, 2026
The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPCKohei Hashimoto, Kouji Izumi, Takashi Shima, et al.
Anticancer Research|October 1, 2021
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell CarcinomaYohei Sekino, Kenshiro Takemoto, Daiki Murata, et al.
Anticancer Research|September 3, 2021
P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell CarcinomaYohei Sekino, Kenshiro Takemoto, Daiki Murata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 6, 2021
Tumor contact length of prostate cancer determined by a three-dimensional method on multiparametric magnetic resonance imaging predicts extraprostatic extension and biochemical recurrenceShunsuke Miyamoto, Keisuke Goto, Yukiko Honda, et al.
European Urology Open Science|July 11, 2022
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled TrialKouji Izumi, Takashi Shima, Koji Mita, et al.
The Prostate|September 20, 2024
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCaNobumichi Tanaka, Kouji Izumi, Yasushi Nakai, et al.
Hiroshima Journal of Medical Sciences|November 8, 2011
Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancerJun Teishima, Masahiro Kenjo, Kohei Kobatake, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 17, 2019
Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naïve Japanese men compared with the standard biopsyShinsuke Fujii, Tetsutaro Hayashi, Yukiko Honda, et al.
Pageof 10